Naloxone Viatris (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Viatris, is an opioid antagonist presented as an injectable solution for intravenous use. It reverses the effects of opioid overdose in emergency situations, restoring breathing and consciousness. GNH USA supplies Naloxone Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used to counteract life‑threatening opioid toxicity. - Opioid overdose: rapidly restores normal respiration and consciousness in patients with heroin or prescription‑opioid overdose. - Acute opioid toxicity: reverses severe central nervous system depression caused by accidental or intentional opioid exposure. - Post‑operative opioid reversal: terminates residual opioid analgesia after surgery when rapid awakening is required.

Naloxone may cause a range of adverse reactions, most of which are related to abrupt opioid withdrawal or the drug’s sympathomimetic activity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis following administration. - Sweating: increased perspiration. - Tachycardia: elevated heart rate. - Hypertension: transient rise in blood pressure. - Agitation or anxiety: nervousness or restlessness.

Serious or Rare Side Effects: - Severe hypertension: marked increase in blood pressure requiring medical intervention. - Cardiac arrhythmia: abnormal heart rhythms. - Seizures: rare convulsive episodes. - Pulmonary edema: fluid accumulation in the lungs. - Anaphylaxis: life‑threatening allergic reaction.

Naloxone should be used with careful clinical assessment and monitoring. - Confirm opioid overdose: ensure signs of opioid toxicity before administration. - Monitor vital signs: observe respiratory rate, blood pressure, and heart rate after dosing. - Risk of acute withdrawal: be aware of possible agitation, pain, or hypertension in opioid‑dependent patients. - Hypersensitivity: avoid if the patient has known allergy to naloxone or formulation components. - Pregnancy and lactation: limited data; weigh potential benefits against unknown risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone may interact with other medications that affect the central nervous system or cardiovascular system.

Major Interactions (Avoid): - Opioid agonists: concurrent use can precipitate severe withdrawal and loss of analgesia. - Buprenorphine or mixed agonist‑antagonist opioids: may cause intense precipitated withdrawal. - High‑dose opioid therapy: may reduce the effectiveness of naloxone in reversing overdose.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals withdrawal. - Antihypertensive agents: could exacerbate hypotension after opioid reversal. - Sedatives or CNS depressants: residual sedation may persist despite naloxone administration.